Could a diabetes shot curb alcohol cravings? new trial investigates
NCT ID NCT06015893
First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 7 times
Summary
This study tests whether semaglutide, a drug used for diabetes and weight loss, can help people with alcohol use disorder drink less. About 80 adults will receive either the drug or a placebo shot weekly for 5 months. Researchers will measure changes in drinking, brain activity, and cravings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADDICTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institute on Drug Abuse
Baltimore, Maryland, 21224, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a brain zapping headset curb relapse in addiction?
- Can a smartphone app tame Alcohol-Related liver disease?
- Calm in a room: can sensory therapy soothe the mind?
- Hidden link: addiction and partner violence under the microscope
- Can Weight-Loss drugs outperform diet and exercise for heart health?
- Focusing on strengths, not weaknesses: a new approach to addiction recovery